EUVIMEDEUVIMED entdecken
Crossref

Alzheimer's disease early screening and staged detection with plasma proteome using machine learning and convolutional neural network

Hengyu Qin iD, Xiumin Shi iD, Yibo Zhu iD, Jiacheng Ma, Xiaohong Deng, Lu Wang iD

European Journal of Neuroscience · 2024

DOI: 10.1111/ejn.16392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neuroscience, 2024. Verfasst von Hengyu Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Information and Electronics, Beijing Institute of Technology, Beijing, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Machine Learning, Neural Networks, Computer, Early Diagnosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) stands as the prevalent progressive neurodegenerative disease, precipitating cognitive impairment and even memory loss. Amyloid biomarkers have been extensively used in the diagnosis of AD. However, amyloid proteins offer limited information about the disease process and accurate diagnosis depends on the presence of a substantial accumulation of amyloid deposition which significantly impedes the early screening of AD. In this study, we have combined plasma proteomics with an ensemble learning model (CatBoost) to develop a cost‐effective and non‐invasive diagnostic method for AD. A longitudinal panel has been identified that can serve as reliable biomarkers across the entire progression of AD. Simultaneously, we have developed a neural network algorithm that utilizes plasma proteins to detect stages of Alzheimer's disease. Based on the developed longitudinal panel, the CatBoost model achieved an area under the operating curve of at least 0.90 in distinguishing mild cognitive impairment from cognitively normal. The neural network model was utilized for the detection of three stages of AD, and the results demonstrated that the neural network model exhibited an accuracy as high as 0.83, surpassing that of the traditional machine learning model.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMachine LearningNeural Networks, ComputerEarly DiagnosisBiomarkersProteomeHumansAgedMaleFemaleCognitive DysfunctionProteomicsAged, 80 and over

Stichwörter der Autor:innen

Alzheimer's diseaseearly screeninglongitudinal panelneural networkplasma proteomics

Substanzen

BiomarkersProteome

Autor:innen und Institutionen

  • School of Information and Electronics, Beijing Institute of Technology, Beijing, China.
  • The Department of Information Engineering, The Chinese University of Hong Kong, Hong Kong, China.
  • Changping Laboratory, Beijing, China.
  • Department of Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, China.

ORCID-Profile: Hengyu Qin, Xiumin Shi, Yibo Zhu, Lu Wang

Zitieren

APA

Qin, H., Shi, X., Zhu, Y., Ma, J., Deng, X., & Wang, L. (2024). Alzheimer's disease early screening and staged detection with plasma proteome using machine learning and convolutional neural network. European Journal of Neuroscience. https://doi.org/10.1111/ejn.16392

Vancouver

Qin H, Shi X, Zhu Y, Ma J, Deng X, Wang L. Alzheimer's disease early screening and staged detection with plasma proteome using machine learning and convolutional neural network. European Journal of Neuroscience. 2024. doi:10.1111/ejn.16392

BibTeX
@article{Qin2024,
  author = {Qin, Hengyu and Shi, Xiumin and Zhu, Yibo and Ma, Jiacheng and Deng, Xiaohong and Wang, Lu},
  title = {Alzheimer's disease early screening and staged detection with plasma proteome using machine learning and convolutional neural network},
  journal = {European Journal of Neuroscience},
  year = {2024},
  doi = {10.1111/ejn.16392}
}
Kostenlos starten →